Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
J Epidemiol Community Health ; 63(2): 168-72, 2009 Feb.
Article in English | MEDLINE | ID: mdl-18977808

ABSTRACT

BACKGROUND: Recent studies in childhood cancer suggest that maternal vitamin supplementation may reduce the risk of leukaemia, neuroblastoma and certain types of childhood brain tumours. For example, a previous study found a significantly reduced risk of acute lymphoblastic leukaemia (ALL) but not acute myeloid leukaemia (AML) in children with Down syndrome whose mothers reported any vitamin supplement use prior to knowledge of pregnancy (ALL OR adjusted for confounders 0.51, 95% confidence limits (CL): 0.30, 0.89; AML OR adjusted for confounders 0.92, 95% CL 0.48, 1.76). Recall of exposures, including maternal vitamin supplement use, however, may be difficult and subject to error. Epidemiologists are encouraged to quantitatively adjust for systematic error in study results, but often do not. METHODS: The impact that misclassification of maternal vitamin supplement use may have had on the observed ORs in this study was quantified. Uncertainty analysis was used to calculate ORs adjusted for inaccurate reporting of vitamin supplement use under assumed probability distributions for exposure misclassification parameters. RESULTS: Given our assumptions, adjustment for exposure misclassification yielded ORs that were predominantly more protective for ALL than the crude OR. CONCLUSIONS: Uncertainty analysis can give important insights into the magnitude and direction of error in study results due to exposure misclassification.


Subject(s)
Dietary Supplements/statistics & numerical data , Preconception Care/methods , Precursor Cell Lymphoblastic Leukemia-Lymphoma/prevention & control , Vitamins/administration & dosage , Bias , Child , Down Syndrome/complications , Down Syndrome/epidemiology , Female , Humans , Mental Recall , Preconception Care/statistics & numerical data , Precursor Cell Lymphoblastic Leukemia-Lymphoma/embryology , Precursor Cell Lymphoblastic Leukemia-Lymphoma/epidemiology , Precursor Cell Lymphoblastic Leukemia-Lymphoma/etiology , Pregnancy , Prenatal Exposure Delayed Effects , Uncertainty
2.
Inorg Chem ; 39(5): 1016-20, 2000 Mar 06.
Article in English | MEDLINE | ID: mdl-12526382

ABSTRACT

A series of mono- and dinuclear lanthanum complexes of 15,31-dimethyl-3,11,19,27,33,35-hexaazapentacyclo[27.3.1.1.(5,9)1,(13,17). 1(21,25)]hexatriaconta-5,7,9(33),13,15,17(34),21,23,25(35),29,31, 1(36)-dodecaene-34,36-diol (24RBPyBC, L) have been defined in solution. Their ability to hydrolyze bis(4-nitrophenyl) phosphate, a phosphate diester, was studied. The various metal-coordinated hydroxide nucleophiles that form in solution attack the substrate in the hydrolysis reaction. The dihydroxo dilanthanum complex, L-2La-2(OH), is the most effective catalyst. Its rate constant is 75 times larger than the rate constant for the monohydroxo dilanthanum complex, L-2La-OH. The mononuclear complexes are not as successful as the dinuclear complexes because they have fewer metal ions per complex to act as Lewis acids. They also cannot generate hydroxide nucleophiles at low pH values like the dinuclear complexes can. The reaction has an unusual third-order dependence on the catalyst concentration which is valid for the dinuclear complexes as well as the mononuclear complexes. This implies a mechanism where a metal-coordinated hydroxide nucleophile attacks the phosphorus of the substrate on the side opposite the negatively charged oxygens.

SELECTION OF CITATIONS
SEARCH DETAIL
...